Dublin, Jan. 18, 2024 (GLOBE NEWSWIRE) -- The "Global Esophageal Cancer Market Report 2023" report has been added to ResearchAndMarkets.com's offering.
According to recent industry analysis, the market for esophageal cancer treatments is forecasted to increase from $1.13 billion in 2022 to approximately $1.77 billion by 2027, fueled by a rise in demand for diagnostic and therapeutic services.
Increasing Incidence of Esophageal Cancer Catalyzes Market Growth
As cases of esophageal cancer continue to climb, with projections indicating a significant rise in the coming years, the market for esophageal cancer diagnostics and treatments is set to expand correspondingly. Indeed, the growing need for endoscopic procedures, imaging tests, and biopsies to detect this malignancy is a primary driver behind the market's anticipated growth.
Trends in Esophageal Cancer Treatments: Focus on New Drug Approvals
Among the advancing trends within the sector, new drug approvals remain at the forefront. Pharmaceutical companies are securing FDA approvals for innovative therapies, aimed at enhancing patient outcomes, particularly for those with advanced or metastatic esophageal cancer. Recent approvals have solidified the competitive landscape, heralding promising developments in treatment protocols.
Geographically, North America has historically dominated the market, hosting a substantial share of esophageal cancer treatments and research. However, the Asia Pacific region is rapidly emerging as the fastest-growing market segment, underscoring a heightened focus on addressing this critical healthcare challenge.
The market is buttressed by a robust roster of key players including leading pharmaceutical and biotech firms committed to advancing esophageal cancer therapeutics. Research and development efforts are complemented by strategic acquisitions, aimed at improving early diagnostic measures and fostering timely interventions.
- The comprehensive analysis features a detailed examination of esophageal cancer types, including esophageal squamous-cell carcinoma and esophageal adenocarcinoma.
- The report explores an array of treatment modalities, from chemotherapy to emerging targeted therapies.
- It delineates the distribution channels facilitating access to these treatments, encompassing hospital pharmacies, online pharmacies, and retail pharmacies.
- The study analyzes the broad spectrum of service providers and associated goods, capturing the full scope of the market's revenue streams.
The esophageal cancer market's upward trajectory is elucidated by an in-depth report that offers a panoramic view of current and future market dynamics. This critical research offers stakeholders the data and insights required to navigate this evolving landscape successfully.
Key Attributes:
| Report Attribute | Details |
| No. of Pages | 175 |
| Forecast Period | 2023 - 2027 |
| Estimated Market Value (USD) in 2023 | $1.25 billion |
| Forecasted Market Value (USD) by 2027 | $1.77 billion |
| Compound Annual Growth Rate | 9.1% |
| Regions Covered | Global |
A selection of companies mentioned in this report includes
- Pfizer Inc.
- Johnson & Johnson
- F. Hoffmann-La Roche Ltd.
- Merck & Co. Inc
- AbbVie Inc.
- Bayer AG
- Novartis AG
- Sanofi S.A
- Bristol-Myers Squibb Company
- AstraZeneca PLC
- GlaxoSmithKline Plc.
- Takeda Pharmaceutical Company Limited
- Eli Lilly and Co Ltd.
- Boehringer Ingelheim International GmbH
- Gilead Sciences Inc.
- Amgen Inc.
- Teva Pharmaceutical Industries Ltd.
- Astellas Pharma Inc.
- Daiichi Sankyo Company Limited
- Servier Pharmaceuticals
- Eisai Co. Ltd.
- Sun Pharmaceutical Industries Limited
- Otsuka Pharmaceutical Co. Ltd.
- Ipsen SA
- Dr. Reddy's Laboratories Ltd.
- Seagen Inc.
- Exelixis Inc.
- BeiGene Ltd.
- Clovis Oncology Inc.
- Aslan Pharmaceuticals Ltd.
For more information about this report visit https://www.researchandmarkets.com/r/thxnsl
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Attachment
